Chronic Obstructive Lung Disease (COPD) is a debilitating lung condition that leaves patients unable to breathe or enjoy life. It is also known as emphysema, chronic bronchitis and chronic obstructive asthma. COPD is rated as the third leading killer in the United States, killing approximately 120,000 individuals a year. Persons suffering from COPD also experience chronic disability and often a low quality of life. Sufferers also require a large amount of medical care with its expense and the need to stay near medical facilities and personnel. COPD is a very limiting and deadly disease.
This paper is designed to help readers gain a greater understanding of the use of adult stem cells for COPD and offer a framework for evaluating if stem cell treatment is a potential step for you or your loved one. We will cover the following:
Feel free to skip to sections that provide information that is helpful to you.
Skip to next section
COPD is a chronic condition and therefore typically requires long term medications. The commonly used treatment options are:
With the exception of surgery, these treatment options are all considered supportive. They help the symptoms but do not change the underlying disease. A simplified diagram of these treatments is:
A COPD patient may be prescribed one, several or all of these at one time or another during the course of their illness. Some patients suffer without using any treatments. The effectiveness of treatment varies greatly both between patients and over the course of the illness. Many patients with COPD do very well for many years with exercise with or without medications.
For more information on the treatment of COPD see: http://www.lung.org/lung-disease/copd/living-with-copd/copd-management-tools.html or http://www.guideline.gov/content.aspx?id=23801
If you are a person doing well using these options, this might not be the right time to consider adult stem cell treatment.
Skip to next section
If you are doing well with your current medical therapy, you may not be an ideal candidate for adult stem cell therapy. Persons should consider adult stem cell therapy for COPD include:
Lung changes in COPD
Adult stem cell therapy DOES NOT assure a response in these patients. However, it does offer an alternative that they may wish to consider. We will discuss results below.
Skip to next section
All stem cells, no matter their source, share two important characteristics:
When we obtain stem cells from mature adult tissues they are referred to as adult stem cells. As with all stem cells, the potential exists for adult stem cells to become any type of cell and then make new copies of the new cell type. This ability to become any type of cell and then make as many cells as needed is the reason for so much interest in adult stem cells. We refer to the process of obtaining adult stem cells as harvesting. To be a good tissue for harvesting, a tissue should be easy to harvest and have an abundant number of stem cells. The two tissues that most readily meet these requirements are bone marrow and fat.
Adult stem cells taken from fat are also known as adipose derived adult stem cells. Stem cells from fat have become increasingly attractive because stem cells from fat are easier to obtain and exist in larger numbers than bone marrow adult stem cells.
For more information on stem cells visit:
What are stem cellsor California Stem Cell Center
Skip to next section
It is a simple process to harvest adult stem cells from fat. First we select an area to take the fat like the stomach or leg. The area is marked and sterilized. Next a local anesthetic solution is injected into the area through a small incision. Suction is applied using a syringe with a special tool called a cannula attached. Typically 50 ml (about 1 1.2 oz.) of fat is suctioned for processing.
There can be some swelling and /or bruising after the harvesting procedure. Swelling and bruising typically resolve in about 2-3 weeks. Patients are given a prescription for pain medications in case they need them. An antibiotic is given before the procedure. Since the procedure is done sterilely, no further antibiotics are needed. Applying ice to the harvest area for a few days after the procedure reduces the swelling and bruising.
After harvesting we take the fat and do some simple processing to isolate the adult stem cells. When finished, the final product is called Stromal Vascular Fraction (SVF). SVF is a very powerful mixture of adult stem cells and growth factors. Growth factors are the chemical messengers our bodies use to promote healing and cell growth. Growth factors have sometimes been referred to as text messages between cells. A typical batch of SVF contains up to about 25 million adult stem cells. Each SVF batch also contains a large amount of growth factors. The growth factors harvested in SVF tend to be highly anti-inflammatory. After harvesting and processing the SVF is now ready to be deployed for your COPD. It can also be used for many other disorders. A number of deployment protocols under investigation for a large number of disorders.
For more about the harvesting process please visit: Harvesting adult stem cells
Skip to next section
We refer to the process of actually using the adult stem cells/SVF ( Stromal Vascular Fraction ) as deployment. The typical deployment for COPD is intravenous. We also nebulize a small amount of the stme cells/SVF and have the patient inhale it.
The IV is started in the office and the stem cells/SVF is injected into a small IV bag. This is then given to the patient over 20-30 minutes. The nebulizer is given during the time the IV is running. When the nebulizer and IV are finished, the IV is discontinued and the patient is discharged.
Skip to next section
Although research is in progress, there are currently no treatment groups large enough to answer this question conclusively. It is important to be aware that the Food and Drug Administration (FDA) has NOT approved the use of adult stem cells/SVF ( Stromal Vascular Fraction ) for any disorder including COPD. Understanding these issues, we do have enough experience to talk about early trends in therapy.
Around 90% of patients respond to deployment with adult stem cells/SVF. The most common response is an increase in exercise ability. Patients feel they can walk further without becoming winded. Patients also note an increase in their oxygen saturation levels (O2 sat). Most patients respond to only one deployment. Some require a repeat deployment in 3-6 months.
This is one of the most common questions asked by our adult stem cell/SVF ( Stromal Vascular Fraction ) patients. Response to deployment for COPD varies from a few days to about 3 months. If a patient has not seen a significant improvement after about 3 months, we recommend a repeat deployment. Many patients continue to see improvement for several months. When they plateau or regress, we then consider a repeat deployment for them as well.
Most of the time repeat deployment is done after the patient has seen some improvement and more improvement is sought. Occasionally, repeat deployment is done because the patient has lost some improvement previously seen. The question of how many deployments are best and how often they are needed is an area of intense interest and study at this time. It is too early to say conclusively that adult stem cells treatment promotes the growth of new lung cells.
We hope we have answered the majority of your questions. If you have others or wish to schedule a consultation please call: 214-420-7970.
Follow this link:
Treatment for Chronic Obstructive Pulmonary Disease Dallas
- What It's Like to Grow a 'Mini-Brain' From Your Own Cells - Discover Magazine - May 25th, 2020
- Canine Stem Cell Therapy Market Covid-19 Impact In 2026 | In-depth Analysis, Global Market Share, Top Trends, Professional & Technical Industry... - May 25th, 2020
- Newborn in Japan receives first treatment with liver STEM cells - ZME Science - May 23rd, 2020
- Adult Stem Cells Market with Coronavirus (Covid-19) Impact Analysis | Industry Strong Development By Major Eminent Players, New Innovations, Key... - May 16th, 2020
- Stem Cell and Regenerative Therapy Market Covid-19 Impact Analysis, Size, Share & Trends Analysis Report by Component, By Enterprise Size, By End... - May 16th, 2020
- The RNA binding protein CPEB2 regulates hormone sensing in mammary gland development and luminal breast cancer - Science Advances - May 16th, 2020
- Stem Cells Market Market Developments and Analysis (impact of Covid-19) 2020-2026 - Herald Writeup - May 15th, 2020
- Takeda Pharmaceutical : China announces ADCETRIS (brentuximab vedotin) is approved for the treatment of adult patients with CD30-positive Lymphomas -... - May 15th, 2020
- New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European... - May 14th, 2020
- Dlp-mediated Hh and Wnt signaling interdependence is critical in the niche for germline stem cell progeny differentiation - Science Advances - May 14th, 2020
- Little Skates Could Hold the Key to Cartilage Therapy in Humans - Technology Networks - May 14th, 2020
- Strides in Medical Tourism Market Key Driver of Low-cost Patient Care in Globalized Healthcare Systems, Notes TMR - PR Newswire UK - May 14th, 2020
- Australia's Mesoblast raises $90M to scale up stem cell therapy manufacturing to treat COVID-19 ARDS - BioWorld Online - May 14th, 2020
- CTX001 for Treatment of Sickle Cell Disease and Other Blood Disorders - Sickle Cell Anemia News - May 14th, 2020
- Stem cells therapy A prospective treatment against coronavirus? - Daily Excelsior - May 14th, 2020
- Protocol Management, Off-the-Shelf Therapies Help Bring CAR T Into More Settings - Targeted Oncology - May 13th, 2020
- BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn for The European Union - Yahoo Finance - May 13th, 2020
- CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001 for the... - May 13th, 2020
- Study: Want to lose weight? Get rid of that pesky nose - The Big Smoke Australia - May 13th, 2020
- Region 3: Immune and Cellular Tx, Part II - MedPage Today - May 9th, 2020
- Rituximab Offers No Extra Benefit to Induction Chemo in ALL - Medscape - May 9th, 2020
- ROCKET PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com - May 9th, 2020
- BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn for The European Union - BioSpace - May 7th, 2020
- Stem Cells Market 2020 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and... - May 7th, 2020
- Chinas scientists accused of playing God by creating monstrous cloned apes and primates with human organs - The Sun - May 7th, 2020
- Roeland Nusse receives Canada's Gairdner International Award | The Dish - Stanford University News - May 7th, 2020
- Broad Foundation brings together stem cell scientists, engineers and physicians at University of Southern - Mirage News - May 7th, 2020
- Schizophrenia drug points to improved brain cancer radiation therapy - New Atlas - May 7th, 2020
- Scientists finally explained one of the strangest coronavirus symptoms - BGR - May 5th, 2020
- What Do New Neurons in the Brains of Adults Actually Do? - The Scientist - May 5th, 2020
- Therapy Harnesses Immune System to Slow Progression of DIPG Brain Tumors - University of Michigan Health System News - May 5th, 2020
- Acute Myeloid Leukemia Therapeutics Market Latest Innovations, Drivers and Industry Key Events During Forecast 2017 2025 - Jewish Life News - May 5th, 2020
- Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M - Xconomy - May 4th, 2020
- Teva and Celltrion Healthcare Announce the Launch of TRUXIMA (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Biosimilar to Rituxan... - May 4th, 2020
- Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), for the Treatment... - May 4th, 2020
- Stem cell therapy shows 83% survival of Coronavirus patients on ventilators - International Business Times, Singapore Edition - April 26th, 2020
- There's no treatment for COVID-19, but Virginia researchers are ramping up clinical trials to try to find one - Richmond.com - April 26th, 2020
- Newest American Academy of Arts and Sciences members | Stanford News - Stanford University News - April 26th, 2020
- 'I Will Not Kill Children to Live' - Church Militant - April 24th, 2020
- Morning Update: Canadas data gaps are hurting our ability to fight the pandemic - The Globe and Mail - April 24th, 2020
- Adult Stem Cell - an overview | ScienceDirect Topics - April 12th, 2020
- Coronavirus updates: Masks required for take out; N.J. hospitalizations to peak within 3 weeks; Stimulus paym - NJ.com - April 12th, 2020
- 4 ways to promote neurogenesis in your brain - Big Think - April 9th, 2020
- Funding roundup: At-home medical exams and a Parkinson's treatment - MedCity News - April 9th, 2020
- Moderna: A $12 Billion Brand Built On Hope And mRNA - Seeking Alpha - April 9th, 2020
- BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority - Yahoo Finance - April 3rd, 2020
- Post-Remission Therapy For AML: Allogeneic Stem-Cell Transplant - SurvivorNet - April 3rd, 2020
- Intermittent fasting might boost the creation of new neurons in a key brain structure - PsyPost - April 3rd, 2020
- 4 relationship problems that can be linked back to early childhood - Big Think - March 28th, 2020
- Scientists Have 'Reset' The Cellular Age Of Cells Taken From A 114-Year-Old Woman - IFLScience - March 26th, 2020
- The Answer to the Coronavirus Is More Abortion? - Townhall - March 24th, 2020
- Mesoblast limited (NASDAQ:MESO) Given Consensus Rating of Buy by Brokerages - Redmond Register - March 21st, 2020
- Stem Cell And Regenerative Therapy Market 2019-2024 Chain Analysis, Upstream Raw Materials Sourcing and Downstream Buyers - Feed Road - March 15th, 2020
- Scientists Create Human 'Body-On-A-Chip' Featuring Tiny Replica Organs In The Lab - IFLScience - March 14th, 2020
- Adult Stem Cells - March 12th, 2020
- Australia's Mesoblast plans to evaluate its stem cell therapy in patients infected with COVID-19 - BioWorld Online - March 12th, 2020
- How to build a body from scratch, Altered Carbon-style - SYFY WIRE - March 12th, 2020
- Astronauts growing new organs on International Space Station - The Independent - March 12th, 2020
- The Inside Scoop on Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) - MicroCap Daily - March 9th, 2020
- Adult Stem Cells: Market 2020 New Innovative Solutions to Boost Global Growth with New Technology, Key Business Strategies, Trend and Forecasts 2024 -... - March 6th, 2020
- Review Finds The Effects Of Obesity On The Body Mirror Those Of Aging - IFLScience - February 29th, 2020
- Stem Cells Market is expected to reach US$270.5 billion by 2025, TMR - BioSpace - February 24th, 2020
- Olive Oil Consumption Could Lead to a 'Younger Brain' in the Elderly, Researchers Say - Olive Oil Times - February 24th, 2020
- New sickle cell disease treatments are helping people live longer and giving them a higher quality of life - PhillyVoice.com - February 24th, 2020
- Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in... - February 24th, 2020
- Transplant for Szary Syndrome is Patient's First Step in Returning to the Dance Floor - Dana-Farber Cancer Institute - February 22nd, 2020
- Eternal youth and good health from stem cells soon within reach? - Innovation Origins - February 22nd, 2020
- How do body parts grow to their right sizes? - The Week Magazine - February 22nd, 2020
- 8-year-old bone marrow recipient and donor celebrate in emotional reunion - WFAA.com - February 16th, 2020
- Singapore researchers discover Human Stem Cells and Cancer Origins in Stomach - BSA bureau - February 14th, 2020
- Stem Cell And Regenerative Therapy Market Sales Volume, Status, Growth, Opportunities and World - Instant Tech News - February 14th, 2020
- Astrocytes could be harnessed to protect motor neurons in MND - Drug Target Review - February 11th, 2020
- BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn Regulatory Pathway for Approval in ALS - Yahoo Finance - February 11th, 2020
- Mexico City Medical Congress to Showcase the Global Stem Cells Group's Latest Innovations - PRUnderground - February 11th, 2020
- Bone Therapeutics to present preclinical data on the osteogenic properties of ALLOB in bone repair at the Annual Meeting of the Orthopaedic Research... - February 11th, 2020
- Stopping Smoking Allows Healthy Lung Cells to Proliferate - Medscape - February 6th, 2020
- Biological robots, that is a thing now - 702 - February 6th, 2020
- How the next trip to the moon will get us ready for Mars - Deseret News - February 6th, 2020
- Knocking Down Levels Of These Proteins Could Reverse Type 2 Diabetes - International Business Times - February 6th, 2020
- Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal C | CCID - Dove Medical Press - February 2nd, 2020